Quick Answer
Inmune Bio, Inc. reported Long-Term Debt of $9.70 million for fiscal year 2022.
Inmune Bio, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2022 | $9.70M | — |
- The most recent figure is from Inmune Bio, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: